World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
9606
World Ranking
13416
National Ranking
952

Overview

Viktor Magdolen is affiliated with the Technical University of Munich in Germany. Their research spans several fields, primarily focusing on medicine and biochemistry, genetics, and molecular biology. Within these broader fields, the scientist's work concentrates on molecular biology, oncology, genetics, cancer research, and immunology.

The scientist has contributed to topics including coagulation, bradykinin, polyphosphates, and angioedema; peptidase inhibition and analysis; RNA modifications and cancer; cancer mechanisms and therapy; phytochemical compounds' biological activities; immune cell function and interaction; and ovarian cancer diagnosis and treatment.

Viktor Magdolen's frequent coauthors include Tobias Dreyer, Julia Dorn, Marion Kiechle, Holger Bronger, and Ute Reuning.

The scientist frequently publishes in several venues, notably:

  • Cancers
  • Alzheimer s & Dementia
  • Molecular Medicine
  • British Journal of Cancer
  • Nature Chemical Biology

Recent papers by Viktor Magdolen include:

  • "CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer," 2022, British Journal of Cancer
  • "tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression," 2021, Cancers
  • "Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1," 2021, Nature Chemical Biology
  • "Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma," 2021, Cancers
  • "The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer In Vitro and In Vivo," 2021, Cancer Immunology Research

Best Publications

  • Clinical impact of the plasminogen activation system in tumor invasion and metastasis : Prognostic relevance and target for therapy

    M Schmitt;N Harbeck;C Thomssen;O Wilhelm

  • Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences.

    Mekdes Debela;Mekdes Debela;Viktor Magdolen;Norman Schechter;Martina Valachova;Martina Valachova

  • Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer

    Nadia Harbeck;Ronald E. Kates;Katja Gauger;Amina Willems

  • Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro

    Gwendalyn J. Randolph;Gwendalyn J. Randolph;Gwendalyn J. Randolph;Thomas Luther;Thomas Luther;Thomas Luther;Sybille Albrecht;Sybille Albrecht;Sybille Albrecht;Viktor Magdolen;Viktor Magdolen;Viktor Magdolen

  • Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.

    Olaf G. Wilhelm;Sabine Wilhelm;Gemma M. Escott;Verena Lutz

  • Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.

    Achim Krüger;Rita Soeltl;Igor Sopov;Charlotte Kopitz

  • Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

    Peter Goettig;Viktor Magdolen;Hans Brandstetter

  • The intron-containing gene for yeast profilin (PFY) encodes a vital function.

    Viktor Magdolen;Ulrich Oechsner;Gunter Muller;Wolfhard Bandlow

  • The urokinase plasminogen activator system as a novel target for tumour therapy

    M. Schmitt;O.G. Wilhelm;U. Reuning;A. Krüger

  • The α and β Subunits of the Metalloprotease Meprin Are Expressed in Separate Layers of Human Epidermis, Revealing Different Functions in Keratinocyte Proliferation and Differentiation

    Christoph Becker-Pauly;Markus Höwel;Tatjana Walker;Annica Vlad

  • The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10

    Tamara Jefferson;Ulrich Auf dem Keller;Ulrich Auf dem Keller;Caroline Bellac;Verena V. Metz

  • (4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.

    Stefan Sperl;Uwe Jacob;Nuria Arroyo de Prada;Jörg Stürzebecher

  • Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.

    Panagiotis Prezas;Matthias J E Arlt;Petar Viktorov;Antoninus Soosaipillai

  • Structural basis of the zinc inhibition of human tissue kallikrein 5.

    Mekdes Debela;Peter Goettig;Viktor Magdolen;Robert Huber

  • Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein 7

    Mekdes Debela;Petra Hess;Viktor Magdolen;Norman M. Schechter

  • DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.

    Inko Nimmrich;Anieta M. Sieuwerts;Marion E. Meijer-van Gelder;Ina Schwope

  • Systematic Mutational Analysis of the Receptor-Binding Region of the Human Urokinase-Type Plasminogen Activator

    Viktor Magdolen;Peter Rettenberger;Marcus Koppitz;Lothar Goretzkt

  • Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue.

    T Luther;V Magdolen;S Albrecht;M Kasper

  • Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.

    Mekdes Debela;Nathalie Beaufort;Viktor Magdolen;Norman M Schechter

  • Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1.

    Buddy Setyono-Han;Jörg Stürzebecher;Wolfgang A. Schmalix;Bernd Muehlenweg

Frequent Co-Authors

Manfred Schmitt
Manfred Schmitt Technical University of Munich
Horst Kessler
Horst Kessler Technical University of Munich
Eleftherios P. Diamandis
Eleftherios P. Diamandis Mount Sinai Hospital
Judith A. Clements
Judith A. Clements Queensland University of Technology
Fred C.G.J. Sweep
Fred C.G.J. Sweep Radboud University
John A. Foekens
John A. Foekens Erasmus University Rotterdam
Friedrich Lottspeich
Friedrich Lottspeich Max Planck Society
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Hans Brandstetter
Hans Brandstetter University of Salzburg
Christian P. Sommerhoff
Christian P. Sommerhoff Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens doors to rewarding careers in healthcare, research, and technology. Many students consider pathways such as medical coding, which can be highly flexible and lucrative. If you're curious about compensation, check out the current statistics for medical coding salary.

With rapid changes in healthcare, some wonder is medical coding a dying career or if it's still a viable option. Staying informed can help you make the best choice for your future.

For those interested in data and administration, pursuing a him degree (Health Information Management) can lead to critical roles managing patient data and ensuring healthcare compliance.

Additionally, students passionate about health and wellness can consider an online nutrition masters, a growing field with diverse career opportunities in clinical, research, and public health settings.

Best Scientists Citing Viktor Magdolen

Trending Scientists

Recently Published Articles